CONTROLLED CONCENTRATION ELECTROLYSIS SYSTEM

Details for Australian Patent Application No. 2003267200 (hide)

Owner METALLIC POWER, INC.

Inventors DES JARDINS, Stephen, R.; SMEDLEY, Stuart, I.

Pub. Number AU-A-2003267200

PCT Number PCT/US03/28894

PCT Pub. Number WO2004/024990

Priority 60/410,429 12.09.02 US; 60/410,426 12.09.02 US; 60/410,548 12.09.02 US; 60/410,565 12.09.02 US; 60/410,590 12.09.02 US; 10/424,539 24.04.03 US

Filing date 12 September 2003

Wipo publication date 30 April 2004

International Classifications

C25B 001/00 Electrolytic production of inorganic compounds or non-metals

C25B 015/00 Operating or servicing of cells

C25C 001/00 Electrolytic production, recovery or refining of metals by electrolysis of solutions

H01M 008/00 Fuel cells

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/410,429 12.09.02 US; 60/410,426 12.09.02 US; 60/410,548 12.09.02 US; 60/410,565 12.09.02 US; 60/410,590 12.09.02 US; 10/424,539 24.04.03 US

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003267200

16 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267201-Structurally rigid dopamine D3 receptor selective ligands and process for making them

2003267199-HUMAN KININOGEN D3 DOMAIN POLYPEPTIDE AS AN ANTIANGIOGENIC AND ANTI-TUMOR AGENT